Bridging the Gaps: Exploring the Links Between Prurigo Nodularis and Chronic Itch
Prurigo nodularis (PN) is far more than just a persistent itch—it is a distinct, neuroimmune-driven disease entity that demands its own targeted diagnostic and therapeutic roadmap. During a standout session at this year's Skin of Color Update in New York City, Dr. Raj Chovatiya challenged the long-held notion that PN is merely a variant of atopic dermatitis. For patients with skin of color, wher …
Prurigo nodularis (PN) is far more than just a persistent itch—it is a distinct, neuroimmune-driven disease entity that demands its own targeted diagnostic and therapeutic roadmap. During a standout session at this year's Skin of Color Update in New York City, Dr. Raj Chovatiya challenged the long-held notion that PN is merely a variant of atopic dermatitis. For patients with skin of color, wher … Continue reading "Bridging the Gaps: Exploring the Links Between Prurigo Nodularis and Chronic Itch"
Artificial intelligence (AI) is rapidly changing dermatology, and combining AI with dermoscopy is promising unprecedented diagnostic precision. However, as these technologies advance, a critical question remains: Are they designed to serve all patients equally?
Current diagnostic tools often underperform in patients with skin of color due to biases in training data and a lack of standardized i … 
Throughout your dermatology training, you will pour over thousands of clinical photographs as you learn to identify various conditions. This will be coupled with viewing patients in person and learning to identify subtleties in morphology and presentation to make a diagnosis. No matter how robust and busy your training center is, it would be impossible to see everything. Therefore, the clinical im … 
Managing hair loss in patients with skin of color requires a nuanced understanding of both medical and supplemental therapies. In a detailed presentation, Maryanne Senna, MD, explored the evidence behind over-the-counter (OTC) and procedural interventions for various alopecias. As patients increasingly seek supplemental and at-home options, clinicians must be equipped to distinguish between scie … 
Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …